Clinical Trial Update: TS-1 in Combination With Calcium Folinate in Patients With Heavily Pre-treated mCRC [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating TS-1 in combination with calcium folinate in heavily pre-treated metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Calcium folinate (calcium folinate)
• TS-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: TTY Biopharm | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED